Alexander Gaber

1.2k total citations
29 papers, 791 citations indexed

About

Alexander Gaber is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alexander Gaber has authored 29 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alexander Gaber's work include Genetic factors in colorectal cancer (6 papers), Esophageal Cancer Research and Treatment (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Alexander Gaber is often cited by papers focused on Genetic factors in colorectal cancer (6 papers), Esophageal Cancer Research and Treatment (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Alexander Gaber collaborates with scholars based in Sweden, Finland and Ireland. Alexander Gaber's co-authors include Karin Jirström, Björn Nodin, Mathias Uhlén, Jakob Eberhard, Sakarias Wangefjord, Anders Bjartell, Jonas Manjer, Fredrik Pontén, Charlotta Hedner and Kajsa Ericson Lindquist and has published in prestigious journals such as PLoS ONE, Cancer Research and British Journal of Cancer.

In The Last Decade

Alexander Gaber

29 papers receiving 778 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Alexander Gaber 365 296 224 166 161 29 791
Katherine C. Kurnit 327 0.9× 294 1.0× 231 1.0× 146 0.9× 99 0.6× 48 987
Peter Jo 476 1.3× 440 1.5× 279 1.2× 150 0.9× 157 1.0× 28 924
Matteo Ghilli 247 0.7× 308 1.0× 306 1.4× 146 0.9× 156 1.0× 43 794
Jianjun Yu 455 1.2× 217 0.7× 198 0.9× 276 1.7× 125 0.8× 52 943
Kit Curtius 303 0.8× 238 0.8× 270 1.2× 194 1.2× 251 1.6× 36 825
María D. Giraldez 438 1.2× 342 1.2× 331 1.5× 85 0.5× 169 1.0× 32 926
Matin Sheriff 364 1.0× 551 1.9× 170 0.8× 193 1.2× 168 1.0× 33 1.0k
Haiqing Luo 389 1.1× 319 1.1× 287 1.3× 144 0.9× 71 0.4× 36 823
Andrew P. Sciallis 225 0.6× 254 0.9× 172 0.8× 162 1.0× 96 0.6× 39 770

Countries citing papers authored by Alexander Gaber

Since Specialization
Citations

This map shows the geographic impact of Alexander Gaber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Gaber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Gaber more than expected).

Fields of papers citing papers by Alexander Gaber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Gaber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Gaber. The network helps show where Alexander Gaber may publish in the future.

Co-authorship network of co-authors of Alexander Gaber

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Gaber. A scholar is included among the top collaborators of Alexander Gaber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Gaber. Alexander Gaber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Polistena, Andrea, Alexander Gaber, Björn Nodin, et al.. (2018). MMP7 Modulation by Short- and Long-term Radiotherapy in Patients with Rectal Cancer. In Vivo. 32(1). 133–138. 6 indexed citations
2.
Borg, David, Charlotta Hedner, Alexander Gaber, et al.. (2016). Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma. Biomarker Research. 4(1). 10–10. 26 indexed citations
3.
Bergenfelz, Caroline, Alexander Gaber, Roni Allaoui, et al.. (2015). S100A9 expressed in ER−PgR− breast cancers induces inflammatory cytokines and is associated with an impaired overall survival. British Journal of Cancer. 113(8). 1234–1243. 28 indexed citations
4.
Nodin, Björn, Alexander Gaber, Jakob Eberhard, et al.. (2015). Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer. PLoS ONE. 10(3). e0121300–e0121300. 20 indexed citations
5.
Elebro, Jacob, Margareta Heby, Alexander Gaber, et al.. (2014). Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma. Journal of Translational Medicine. 12(1). 289–289. 41 indexed citations
6.
Hedner, Charlotta, Alexander Gaber, Björn Nodin, et al.. (2014). SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(6). 649–659. 25 indexed citations
7.
Berntsson, Jonna, Sebastian Lundgren, Björn Nodin, et al.. (2014). Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer. Journal of Ovarian Research. 7(1). 26–26. 23 indexed citations
8.
9.
10.
Elebro, Jacob, Alexander Gaber, Margareta Heby, et al.. (2014). Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis. PLoS ONE. 9(11). e112728–e112728. 21 indexed citations
11.
Andersson, G., Alexander Gaber, Björn Nodin, et al.. (2014). Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts. BMC Urology. 14(1). 36–36. 17 indexed citations
12.
Eberhard, Jakob, Alexander Gaber, Sakarias Wangefjord, et al.. (2012). A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer. British Journal of Cancer. 106(5). 931–938. 91 indexed citations
13.
Larsson, Anna, Alexander Gaber, Björn Nodin, et al.. (2012). Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer. BMC Cancer. 12(1). 282–282. 37 indexed citations
14.
Gaber, Alexander, Kristina Hotakainen, Björn Nodin, et al.. (2011). Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients. Radiation Oncology. 6(1). 100–100. 5 indexed citations
15.
Wangefjord, Sakarias, Jonas Manjer, Alexander Gaber, et al.. (2011). Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study. Biology of Sex Differences. 2(1). 10–10. 28 indexed citations
16.
Brennan, Donal J., Jakob Eberhard, Björn Nodin, et al.. (2011). High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer. PROTEOMICS - CLINICAL APPLICATIONS. 5(11-12). 624–635. 43 indexed citations
17.
Gaber, Alexander, et al.. (2011). High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression. Diagnostic Pathology. 6(1). 91–91. 43 indexed citations
18.
Dahlman, Anna, Elton Rexhepaj, Donal J. Brennan, et al.. (2011). Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis. Modern Pathology. 24(5). 708–719. 29 indexed citations
19.
Gaber, Alexander, Martin Johansson, Ulf‐Håkan Stenman, et al.. (2009). High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. British Journal of Cancer. 100(10). 1540–1548. 54 indexed citations
20.
Borgquist, Signe, Soraya Djerbi, Fredrik Pontén, et al.. (2008). HMG‐CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors. International Journal of Cancer. 123(5). 1146–1153. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine C. Kurnit Breakdown of academic impact, for papers by Peter Jo Breakdown of academic impact, for papers by Matteo Ghilli Breakdown of academic impact, for papers by Jianjun Yu Breakdown of academic impact, for papers by Kit Curtius Breakdown of academic impact, for papers by María D. Giraldez Breakdown of academic impact, for papers by Matin Sheriff Breakdown of academic impact, for papers by Haiqing Luo Breakdown of academic impact, for papers by Andrew P. Sciallis
Rankless by CCL
2026